Pharmaceutical company PharmaLogic Holdings Corp. announced on Friday that it has opened a new radiopharmaceutical production and research facility in Salt Lake City, Utah.

This expansion supports the company's mission to provide life-saving diagnostic and therapeutic radiopharmaceuticals across North America.

The location choice reflects PharmaLogic's commitment to improving access to essential radiopharmaceuticals in the Canyons region. The facility is designed to scale existing operations while advancing research and development efforts for novel treatments. This investment positions PharmaLogic to further innovate and meet growing market demand.